Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
- PMID: 11133376
- DOI: 10.1086/318075
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
Abstract
Pseudomonas aeruginosa lung infection is an important cause of morbidity and mortality in cystic fibrosis (CF). Longitudinal assessment of the phenotypic changes in P. aeruginosa isolated from young children with CF is lacking. This study investigated genotypic and phenotypic changes in P. aeruginosa from oropharynx (OP) and bronchoalveolar lavage fluid (BALF) in a cohort of 40 CF patients during the first 3 years of life; antibody response was also examined. A high degree of genotypic variability was identified, and each patient had unique genotypes. Early isolates had a phenotype distinct from those of usual CF isolates: generally nonmucoid and antibiotic susceptible. Genotype and phenotype correlated between OP and BALF isolates. As determined by culture, 72.5% of patients demonstrated P. aeruginosa during their first 3 years. On the basis of combined culture and serologic results, 97.5% of patients had evidence of infection by age 3 years, which suggests that P. aeruginosa infection occurs early in CF and may be intermittent or undetectable by culture.
Comment in
-
Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.J Infect Dis. 2002 Jan 15;185(2):269-70. doi: 10.1086/338197. J Infect Dis. 2002. PMID: 11807706 No abstract available.
Similar articles
-
Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis.Thorax. 2010 Nov;65(11):985-90. doi: 10.1136/thx.2009.132845. Epub 2010 Oct 1. Thorax. 2010. PMID: 20889526
-
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.Pediatr Pulmonol. 2002 Aug;34(2):91-100. doi: 10.1002/ppul.10127. Pediatr Pulmonol. 2002. PMID: 12112774
-
Pseudomonas aeruginosa diversity in distinct paediatric patient groups.Clin Microbiol Infect. 2008 Oct;14(10):935-41. doi: 10.1111/j.1469-0691.2008.02054.x. Epub 2008 Aug 26. Clin Microbiol Infect. 2008. PMID: 18752596
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
-
Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.APMIS Suppl. 1994;46:1-44. APMIS Suppl. 1994. PMID: 7811529 Review.
Cited by
-
Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.PLoS Genet. 2015 Jun 5;11(6):e1005273. doi: 10.1371/journal.pgen.1005273. eCollection 2015 Jun. PLoS Genet. 2015. PMID: 26047157 Free PMC article.
-
Functional Amyloids in Pseudomonas aeruginosa Are Essential for the Proteome Modulation That Leads to Pathoadaptation in Pulmonary Niches.Microbiol Spectr. 2023 Feb 14;11(1):e0307122. doi: 10.1128/spectrum.03071-22. Epub 2022 Dec 8. Microbiol Spectr. 2023. PMID: 36475836 Free PMC article.
-
Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis.Respir Res. 2012 Oct 2;13(1):87. doi: 10.1186/1465-9921-13-87. Respir Res. 2012. PMID: 23031195 Free PMC article.
-
Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population.J Bacteriol. 2012 Apr;194(8):2062-73. doi: 10.1128/JB.00022-12. Epub 2012 Feb 17. J Bacteriol. 2012. PMID: 22343293 Free PMC article.
-
Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.Antimicrob Agents Chemother. 2007 May;51(5):1813-7. doi: 10.1128/AAC.01037-06. Epub 2007 Mar 12. Antimicrob Agents Chemother. 2007. PMID: 17353241 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous